SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-011653
Filing Date
2020-06-23
Accepted
2020-06-23 16:35:00
Documents
6
Period of Report
2020-06-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 36696
2 ex10-1.htm EX-10.1 61130
3 ex99-1.htm EX-99.1 13412
4 ex10-1_001.jpg GRAPHIC 5539
5 ex10-1_002.jpg GRAPHIC 26133
6 ex99-1_001.jpg GRAPHIC 3790
  Complete submission text file 0001493152-20-011653.txt   162026
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 20982591
SIC: 2834 Pharmaceutical Preparations